Full Press Release Details
Therapeutics Limited (ASX: ATH) - Trading Halt
securities of Alterity Therapeutics Limited ( ATH') will be placed in trading halt at the request of ATH, pending it releasing
an announcement. Unless ASX decides otherwise, the securities will remain in trading halt until the earlier of the commencement of normal
trading on Monday, 26 February 2024 or when the announcement is released to the market.
| 22 February 2024 Market Announcement 1/1 | |
| ASX Limited | ASX Customer Service Centre 131 279 | asx.com.au |
Adviser, Listings Compliance (Melbourne)
ASX Compliance Pty Ltd
50, South Tower, Rialto
| By email: | TradingHaltsMelbourne@asx.com.au |
| ListingsComplianceMelbourne@asx.com.au |
for a trading halt - Alterity Therapeutics Limited
accordance with ASX Listing Rule 17.1, Alterity Therapeutics Limited (ASX: ATH, NASDAQ: ATHE) (the Company) requests that its
securities be placed into an immediate trading halt pending an announcement in relation to a capital raise.
Company requests that trading in its securities be halted until after the expected announcement is made or until the market opens on
Monday, 26 February 2024, whichever is the earlier.
Company is not aware of any reason why this trading halt request should not be granted or of any other information necessary to inform
the market about the trading halt.
contact me if you require any further information.
Alterity Therapeutics Limited
Level 14, 350 Collins Street, Melbourne,
T: +61 (0)3 9349 4906 | www.alteritytherapeutics.com